ESCMID eLibrary

Search results

Icon explanation

close

Abstract

ePoster

Handout

Image

Journal Article

Presentation

Video

Webcast

1. O511

   Performance of a new gelified nested-polymerase chain reaction (PCR) test for the diagnosis of imported malaria

   Nuria Iglesias, Madrid, Spain

   N. Iglesias*, C. Toro, P. Trevisi, A. Arroyo, M. Subirats, M. Baquero (Madrid, ES)

   30 April 2013

   Session: Parasitic diseases: protozoans

   Relevance:

    

   100%

    

   

   Event: ECCMID 2013
   Berlin, Germany
   Oral presentation

   Parasitic Diseases & International Health

2. O576

   Population pharmacokinetic (popPK)-model of colistin (C) & colistin methanesulfonate (CMS) in critically-ill patients not on renal replacement therapy (RRT)

   samira garonzik, Buffalo, United States

   S. Garonzik, A. Forrest*, J. Li, V. Thamlikitkul, E. Giamarellos-Bourboulis, S. Shoham, D.L. Paterson, F. Silveira, R.L. Nation (East Hanover, Buffalo, US; Melbourne, AU; Bangkok, TH; Athens, GR; Baltimore, US; Brisbane, AU; Pittsburgh, US)

   30 April 2013

   Session: Old drugs, new challenges - PK/PD for glycopeptides and polymyxins

   Relevance:

    

   100%

    

   

   Event: ECCMID 2013
   Berlin, Germany
   Oral presentation

   New Antibacterial Agents & Stewardship

3. O577

   Population pharmacokinetics of colistin methanesulfonate (CMS) and colistin in critically ill patients receiving intermittent haemodialysis

   William Couet, Poitiers, France

   N. Grégoire*, B. Mégarbane, E. Comets, P. Gobin, D. Balayn, O. Mimoz, W. Couet (Poitiers, Paris, FR)

   30 April 2013

   Session: Old drugs, new challenges - PK/PD for glycopeptides and polymyxins

   Relevance:

    

   100%

    

   

   Event: ECCMID 2013
   Berlin, Germany
   Oral presentation

   New Antibacterial Agents & Stewardship

4. O578

   Nephrotoxicity of colistin and role of kidney disease on patient outcomes in infections due to extensively-drug resistant Acinetobacter baumannii

   Roberto Andini, Naples, Italy

   R. Andini, E. Durante Mangoni*, A. Senese, D. Pinto, F. Agrusta, I. Mattucci, V. Farinaro, C. Graziano, C. Battimelli, C. Savinelli, V. Iorio, M. Bassetti, P. Malacarne, N. Petrosillo, C. Viscoli, R. Utili (Naples, Genoa, Pisa, Rome, IT)

   30 April 2013

   Session: Old drugs, new challenges - PK/PD for glycopeptides and polymyxins

   Relevance:

    

   100%

    

   

   Event: ECCMID 2013
   Berlin, Germany
   Oral presentation

   Bacterial Susceptibility & Resistance

5. O579

   Colistin lung alveolar disposition following nebulisation or intravenous administration in rats

   SANDRINE MARCHAND, Poitiers, France

   A. Vidal Lacerda Gontijo, N. Grégoire, I. Lamarche, P. Gobin, W. Couet*, S. Marchand (Poitiers, FR)

   30 April 2013

   Session: Old drugs, new challenges - PK/PD for glycopeptides and polymyxins

   Relevance:

    

   100%

    

   

   Event: ECCMID 2013
   Berlin, Germany
   Oral presentation

   New Antibacterial Agents & Stewardship

6. O580

   In vitro pharmacodynamics of polymyxin B (P) alone and in combination (combi) with tigecycline (T) against extreme-drug-resistant (XDR) Enterobacter cloacae (EC) with decreased susceptibility to polymixin B in a hollow-fibre infection model (HFIM)

   Andrea Kwa, Singapore, Singapore

   Y. Cai, T.P. Lim, J. Teo, S. Sasikala, W. Lee, T.Y. Tan, T.T. Tan, T.H. Koh, L.Y. Hsu, A.L. Kwa* (Singapore, SG)

   30 April 2013

   Session: Old drugs, new challenges - PK/PD for glycopeptides and polymyxins

   Relevance:

    

   100%

    

   

   Event: ECCMID 2013
   Berlin, Germany
   Oral presentation

   New Antibacterial Agents & Stewardship

7. O581

   Is what you see what you get? Product variation in clinical and reference formulations of polymyxin B

   Zahra Kassamali, Chicago, United States

   Z. Kassamali*, W. Wang, R.N. Jones, J. Rotschafer, L. Danziger, R. Prince (Chicago, Houston, North Liberty, Minneapolis, US)

   30 April 2013

   Session: Old drugs, new challenges - PK/PD for glycopeptides and polymyxins

   Relevance:

    

   100%

    

   

   Event: ECCMID 2013
   Berlin, Germany
   Oral presentation

   New Antibacterial Agents & Stewardship

8. O582

   Population pharmacokinetic model leads to hospital-wide improvement in early vancomycin trough concentrations.

   Robert Tilley, Plymouth, United Kingdom

   R. Tilley*, H. Parker (Plymouth, Exeter, UK)

   30 April 2013

   Session: Old drugs, new challenges - PK/PD for glycopeptides and polymyxins

   Relevance:

    

   100%

    

   

   Event: ECCMID 2013
   Berlin, Germany
   Oral presentation

   New Antibacterial Agents & Stewardship

9. O583

   Semi-mechanistic pharmacokinetic-pharmacodynamic (PK-PD) modelling of linezolid and vancomycin against Staphylococcus aureus using an in vitro dynamic system

   William Couet, Poitiers, France

   N. Gregoire*, A. Besseghir, S. Pichereau, W. Rose, W. Couet (Poitiers, FR; Madison, US)

   30 April 2013

   Session: Old drugs, new challenges - PK/PD for glycopeptides and polymyxins

   Relevance:

    

   100%

    

   

   Event: ECCMID 2013
   Berlin, Germany
   Oral presentation

   New Antibacterial Agents & Stewardship

10. O584

    The safety and efficacy of high versus low vancomycin trough level in the treatment of patient with infections caused by methicillin-resistant Staphylococcus aureus: a meta-analysis

    Sasima Tongsai, Bangkok, Thailand

    S. Tongsai*, P. Koomanachai (Bangkok, TH)

    30 April 2013

    Session: Old drugs, new challenges - PK/PD for glycopeptides and polymyxins

    Relevance:

     

    100%

     

    

    Event: ECCMID 2013
    Berlin, Germany
    Oral presentation

    New Antibacterial Agents & Stewardship